NuCana plc
NUC-7738
melanoma
Resolved
7days ago
Phase 2 readout · Jun 30, 2026
What's at stake
Phase 2 trial results for NUC-7738 in melanoma are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 14h ago
“We expect to report data from this expansion study in 2026.”